NCT07315945 Implementation of an Allergic Rhinitis Severity Questionnaire in ENT Consultations
| NCT ID | NCT07315945 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Allergic Rhinitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-06-10 |
| Primary Completion | 2026-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-06-10 with a primary completion date of 2026-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Allergic rhinitis is a very common condition (affecting 1 in 5 people in Europe) and a costly one for society (direct and indirect costs). Symptoms vary depending on the time of year, and treatments are primarily symptomatic, with follow-up in ENT consultations. Scientific societies (EAACI, FDA, EMA) recommend using a universal tool (severity score) (the CSMS score, SCST in French) to monitor severity and follow-up, and to obtain consistent data that can be extrapolated to other scientific data (meta-analyses). Therefore, investigators in the ENT department use this SCST score (as well as others such as the SNOT 22 score) to assess the severity of allergic rhinitis in our patients and its progression. Tbe investigators wish to confirm the acceptability of this tool for patients, and the statistical value of its properties.
Eligibility Criteria
Inclusion Criteria: * Adult (≥18 years) * Follow-up at the ENT department of Hautepierre University Hospital for allergic rhinitis Exclusion Criteria: * Asymptomatic individuals not requiring follow-up consultations.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07315945 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Allergic Rhinitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07315945 currently recruiting?
Yes, NCT07315945 is actively recruiting participants. Contact the research team at lea.fath@chru-strasbourg.fr for enrollment information.
Where is the NCT07315945 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07315945 clinical trial?
NCT07315945 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 30 participants.